LegalizeThe Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2008
Made: 12th November 2008
Laid before Parliament: 19th November 2008
Coming into force: 1st January 2009
In accordance with section 129(6) of that Act, they have consulted such organisations as appear to them to be representative of interests likely to be substantially affected by the Regulations.
Citation and commencement
1
These Regulations may be cited as the Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2008 and come into force on 1st January 2009.
Amendment of the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973
2
In regulation 3 (fees) of the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 19733—
- (a) in paragraph (1), for “£510” (fee for registration of premises, where premises are in Great Britain) substitute “£529”;
- (b) in paragraph (2), for “£162” (retention fee, where premises are in Great Britain) substitute “£168”; and
- (c) in paragraph (3), for “£510” (additional sum by way of penalty, where premises are in Great Britain) substitute “£529”.
Signed
Signed by authority of the Secretary of State for Health.
Phil Hope — Minister of State, — Department of Health — 8th November 2008
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety
Michael McGimpsey — Minister of Health, Social Services and Public Safety — 12th November 2008
Explanatory note
(This note is not part of the Regulations)
EXPLANATORY NOTE
These Regulations further amend the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973 as follows—
- (a) regulation 2(a) increases the fee for registration of premises at which a retail pharmacy business is, or is to be, carried on by 3.7% where the premises are in Great Britain;
- (b) regulation 2(b) increases the retention fee by 3.7% where the premises are in Great Britain; and
- (c) regulation 2(c) increases the penalty for failure to pay a retention fee (payable in the circumstances specified in section 76(2) of the Medicines Act 1968) by 3.7% where the premises are in Great Britain.
A full impact assessment of the effect that this instrument will have on the costs of businesses and the voluntary sector is available from the Department of Health, Skipton House, 80 London Road, London SE1 6LH.
Footnotes
1968 c.67. The expression the “Ministers,” which is relevant to the powers being exercised in the making of these Regulations, is defined in section 1 of the Act as amended by paragraph 1(1) of the Schedule to S.I. 1999/3142 and paragraph 2 of Part 1 of Schedule 8 to S.I. 2006/2407. The word “prescribed,” which is also relevant to the powers being exercised, is defined in section 132(1) of the Act.
By virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c.47) the Department for which the Minister is responsible was renamed by virtue of Article 3(6) of S.I. 1999/283 (N.I. 1).
S.I. 1973/1822; the relevant amending instruments are S.I. 1980/1806 and S.I. 2007/3282.
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.